Nail disorders in infants and children

Related Experiment Video

Updated: Apr 28, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

90.5K

Bianca Maria Piraccini1, Michela Starace

  • 1Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Current Opinion in Pediatrics
|June 3, 2014
PubMed

Insights

Pediatric nail diseases, though uncommon, require expert diagnosis. This review aids in early recognition and management of common congenital, hereditary, inflammatory, infective, and neoplastic nail conditions in children.

Area of Science:

  • Pediatric Dermatology
  • Nail Biology
  • Clinical Diagnostics

Background:

  • Nail diseases in infants and children are infrequently encountered and pose diagnostic challenges.
  • Accurate diagnosis and management are crucial for pediatric patients.

Purpose of the Study:

  • To provide a comprehensive overview of common pediatric nail diseases.
  • To assist healthcare professionals in early recognition and appropriate management of nail disorders in young patients.

Main Methods:

  • Literature review focusing on congenital, hereditary, inflammatory, infective, and neoplastic nail diseases.
  • Synthesis of findings from recent large studies on genetic nail disorders like pachyonychia congenita and epidermolysis bullosa.

Main Results:

  • Recent research highlights clinical findings in genetic nail disorders, including pachyonychia congenita and epidermolysis bullosa.
  • The majority of recent literature focuses on individual case reports, with few comprehensive disease reviews.

Conclusions:

  • Diagnosing pediatric nail conditions can be difficult for non-specialists.
  • Understanding nail anatomy, biology, and pathophysiology is key to accurate diagnosis.
  • This review offers guidance on common nail diseases affecting infants and children.
Abstract

More Related Videos

Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy05:06

Non-Invasive Visualization of Nailbed Microvascular Morphology in Mice Using Capillaroscopy

Published on: February 28, 2025

1.1K
An Intramedullary Locking Nail for Standardized Fixation of Femur Osteotomies to Analyze Normal and Defective Bone Healing in Mice07:41

An Intramedullary Locking Nail for Standardized Fixation of Femur Osteotomies to Analyze Normal and Defective Bone Healing in Mice

Published on: November 13, 2016

13.2K

Related Concept Videos

Accessory Structures of the Skin: Nails01:05

Accessory Structures of the Skin: Nails

Nails are one of the important accessory structures of the skin. They are hard, protective structures that cover the dorsal surface of the distal phalanges of fingers and toes. Nails are composed of specialized keratinized cells and serve various functions, including protection, sensation, and manual dexterity.
The main components of a nail include the following.
Nail Plate: The nail plate is the visible portion of the nail that extends beyond the fingertips or toes. It is a hard, translucent...
3.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
404